Show
Sort by
-
- Journal Article
- A1
- open access
Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux
-
Building bridges for innovation in ageing : synergies between action groups of the EIP on AHA
-
Respiratory hypersensitivity reactions to NSAIDs in Europe : the global allergy and asthma network (GA2LEN) survey
-
- Journal Article
- A1
- open access
ARIA 2016 : care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
-
- Journal Article
- A1
- open access
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
-
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
-
Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma
-
Integrated care pathways for airway diseases (AIRWAYS-ICPs)
-
Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe
-
Chronic rhinosinusitis in Europe: an underestimated disease: a GA²LEN study
-
A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-alpha Blockade in Severe Persistent Asthma
-
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA(2)LEN paper
-
Severe asthma in adults: What are the important questions?
-
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma
-
Improvement of asprinin-intolerant asthma by montelukast, a leukotriene antagonist - A randomized, double-blink, placebo-controlled trial.